BALAXI PHARMACEUTICALS
Back to Cashflow Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-23 Cr | ₹34 Cr | ₹21 Cr | ₹5.53 Cr | ₹-2.32 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BALAXI PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-23 Cr |
| Mar2024 | ₹34 Cr |
| Mar2023 | ₹21 Cr |
| Mar2022 | ₹5.53 Cr |
| Mar2021 | ₹-2.32 Cr |
How is Net Cash Inflow / Outflow of BALAXI PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-23 Cr | Negative | |
| Mar2024 | ₹34 Cr | 62.09 | |
| Mar2023 | ₹21 Cr | 279.94 | |
| Mar2022 | ₹5.53 Cr | Positive | |
| Mar2021 | ₹-2.32 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹142.5 Cr | -7.8% | -14.1% | -66.5% | Stock Analytics | |
| ADANI ENTERPRISES | ₹278,444.0 Cr | -5.1% | -5.4% | -9.8% | Stock Analytics | |
| REDINGTON | ₹21,369.8 Cr | -4.1% | -2.9% | 32.5% | Stock Analytics | |
| MMTC | ₹10,764.0 Cr | -6.4% | 15.2% | -14.9% | Stock Analytics | |
| HONASA CONSUMER | ₹9,370.7 Cr | -3.4% | 10.8% | 16.6% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹9,038.7 Cr | -10.6% | 3.5% | 15.7% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -7.8% |
-14.1% |
-66.5% |
| SENSEX | -1.7% |
-1.4% |
7% |
You may also like the below Video Courses